Courier Therapeutics is a biotechnology startup with a cytotoxic-lymphocyte targeting therapy platform, with a focus on making cancer-immunotherapy safer and more efficacious. Courier's first application of this targeting technology technology, CT101, is a first-in-class IL2R agonist which specifically activates the NK and CD8 T cells against cancer.
View Top Employees from Courier TherapeuticsWebsite | http://www.couriertherapeutics.com |
Employees | 4 (2 on RocketReach) |
Founded | 2015 |
Technologies |
JavaScript,
HTML,
G Suite
+7 more
(view full list)
|
Industry | Biotechnology Research, Biotechnology, Science and Engineering |
Looking for a particular Courier Therapeutics employee's phone or email?
2 people are employed at Courier Therapeutics.